OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

APTOF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Aptose Biosciences (APTOF) Ownership - Who owns Aptose Biosciences?

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Fundamentals

APTOF

Capitalization

4.58M

P/E Ratio

N/A

Risk (Beta)

0.38

Dividend Yield

N/A

Total Cash

3.32M

Total Cash/Share

1.30

Total Debt

10.7M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

-9.13M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

452M

Current Ratio

1.05

Current Revenue Per Employee

101.93

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

N/A

Shares Held By Institutions

893K

Shares Outstanding - Current

2.55M

Total Liabilities

20.1M

Total Volume MTD

N/A

Value

-1

Gain YTD

681.181

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of anticancer therapies with high safety profiles

Industry Biotechnology